46.2 F
New York
HomeHealthUnited States FDA Medical Device Recalls rend and Impact Analysis Report 2023:...

United States FDA Medical Device Recalls rend and Impact Analysis Report 2023: Product Innovation will Reduce Medical Device Recalls

DUBLIN, Jan. 19, 2024 /PRNewswire/ — The “US FDA Medical Device Recalls: Trend and Impact Analysis” report has been added to  ResearchAndMarkets.com’s offering.

This study analyzes the latest US FDA recalls in the medical device market. It does this by examining the FDA’s information summaries. This list includes devices recalled as they presented specific risks to patients.

Rising incidents of patient deaths are raising questions about medical device efficacy, specifically Class II and Class III medical devices. All medical devices commercialized in the US market must adhere to 510(k) compliance. The US Food and Drug Administration (FDA) posts summaries of information about the most serious medical device recalls.

The device types (according to US FDA classification) studied include:

  • Class I recalls
  • Class II recalls

In terms of recalls, devices that could cause serious health issues and even patient death are listed. Medical device recall notices reflect the date of posting on the government list and not the recall initiation date.

FDA Class I Recalls: The FDA Class I is the most crucial recall type. Using Class I medical devices may cause serious injuries or even death.

This recall occurs when a high probability exists that a violative medical device, through exposure or use, causes serious adverse health issues or patient death. Under statutory authority, the FDA can request, conduct, or order a Class I recall. As this recall type includes FDA requests, most companies voluntarily recall their device.

FDA Class II Recalls: An FDA Class II recall occurs when a medical device presents patients with a substantial health and safety hazard. Class II medical device recalls cover devices that have even a slight chance of causing serious injury or producing adverse health consequences, which may be temporary and medically reversible. The FDA issues a Class II recall where the risk of death or severe injury from the device usage is not immediate, but the danger remains.

Key Topics Covered:

1 Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 
  • The Impact of the Top 3 Strategic Imperatives on the Prevention of Medical Device Recalls
  • Growth Opportunities Fuel the Growth Pipeline Engine

2 Growth Opportunity Analysis

  • US FDA Medical Device Recalls
  • Medical Device Recalls – Segmentation
  • Growth Drivers
  • Growth Restraints

3 US FDA Medical Device Recalls, by Year, Type, and Company

  • FDA Steps for Working on 510(k) Approval
  • US FDA Medical Device Recalls – 2018-2023
  • US FDA Medical Device Recalls – Major Recall Reasons
  • US FDA Medical Device Recalls – Number of Recalls by Companies
  • Impact of FDA Recalls on Medical Device Market Participants

4 FDA Class I Recalls

  • Recall 1 – Fresenius Medical Care’s Recall of Hemodialysis Machines
  • Recall 2 – Philips Respironics’s Recall of V60 and V60 Plus Ventilators
  • Recall 3 – Draeger Carina’s Recall of Sub-Acute Care Ventilators Because of Contaminants in Air Path
  • Recall 4 – Covidien LLC (Medtronic) Palindrome and Mahurkar Hemodialysis’s Recall of Catheters
  • Summary of FDA Class I Medical Device Recalls

5 FDA Class II Recalls – Endoscopes and AERs

  • Product Recalls of Endoscopic Devices*
  • AER Product Recalls
  • FDA Communications on Reported Patient Endoscope- and AER-related Infections
  • Factors Leading to the Transition from Reusable and Reprocessed Duodenoscopes to Disposable Duodenoscopes
  • Increased Recommendations to Prevent Cross-contamination Risks Boosting the Flexible Single-use Endoscope Market
  • Case Study – How Boston Scientific Received Additional Centers for Medicare & Medicaid Services (CMS) Reimbursement for the EXALTT Model D Disposable Duodenoscope
  • Summary of Endoscope and AER Recalls and Action Plans

6 Growth Opportunity Universe

  • Growth Opportunity 1: Innovative Chemical and Material Usage in Medical Devices
  • Growth Opportunity 2: New Technology Innovation, such as Flexible Single-use Endoscopes and Disposable Sheaths

A selection of companies mentioned in this report includes

  • Covidien LLC (Medtronic)
  • Draeger Carina
  • Fresenius Medical Care
  • Philips Respironics

For more information about this report visit https://www.researchandmarkets.com/r/z1k458

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Originally published at https://www.prnewswire.com/news-releases/united-states-fda-medical-device-recalls-rend-and-impact-analysis-report-2023-product-innovation-will-reduce-medical-device-recalls-302039330.html
Images courtesy of https://pixabay.com

- Advertising -
- Advertising -
- Part of VUGA -marketing agency
- Advertising -

latest articles

- Advertising -
gossip tv free

explore more

free fashion tv